Understanding the New Multimodality Prognostic Score (MMPS) in Mesothelioma
The Multimodality Prognostic Score (MMPS) is a new tool for evidence-based mesothelioma treatment. It has given clinicians and surgeons a…
-
-
Treatment Combination for Younger Pre-Treated Mesothelioma Patients
There are many systemic therapies recommended for mesothelioma patients. Different therapies may work best for different patient populations. Different therapies… -
A New Prognostic Signature Discovered for Malignant Pleural Mesothelioma
Immune-related genes play an important role in malignant pleural mesothelioma prognosis. They can affect the tumor immune microenvironment and affect… -
New Enzyme Study Highlights a Potential New Mesothelioma Treatment
Maryland researchers say an enzyme in mesothelioma tissues could be key to fighting this deadly cancer. Doctors at the University… -
MicroRNAs in Cancer Development and Mesothelioma Personalized Medicine
A special issue was published in the Journal of Personalized Medicine. Dr. Alessandra Pulliero from the University of Genoa in… -
Mesothelioma and MRI Scans: Using an Old Tool in a New Way
Imaging scans are an important tool in helping clinicians diagnose mesothelioma. These scans include X-rays, CT scans, MRI scans, and… -
Using Electric Fields to Treat Tumors: Combining Standard and Innovative Treatments
Mesothelioma is a rare cancer and standard therapies are limited. So most patients consider one or more different treatments. Different… -
Gender Differences in Men versus Women with Mesothelioma
Asbestos is toxic and cancer-causing for human beings. Asbestos causes mesothelioma and other asbestos related diseases. Asbestos-related diseases affect men… -
Body Swelling and Joint Pain in Malignant Pleural Mesothelioma
The diagnosis of malignant pleural mesothelioma often includes widespread body inflammation. Inflammation and body swelling occur when white blood cells… -
Living With Mesothelioma: Coping Strategies to Find Hope
Mesothelioma is a cancer caused by exposure to asbestos. One key question remains unanswered. How do diagnosed patients experience living…
